A study examined the use of GLP-1 receptor agonists (GLP-1 RAs) in the UK from 2009 to 2017, finding that 45% of the 589 patients initiating GLP-1 RA therapy discontinued within 12 months, with 65% discontinuing within 24 months
Research suggests it may influence nitric oxide signaling (a pathway involved in blood flow and tissue signaling), support angiogenesis, and help regulate inflammatory mediators
Suitable for athletes, weight-loss seekers, fitness enthusiasts, and anyone wanting a clean energy boost without caffeine or stimulants
10.1111/bcpt.13306 96 YuzefovychL
10.1164/rccm.201711-2242OC 89 RaishM.AhmadA.AnsariM
Supporting this with appropriate nutrition, including adequate protein to maintain gut epithelial cell turnover, represents a logical adjunct